ATE509107T1 - Aufreinigung von fc-tact-fusionsproteinen unter verwendung der ölkörper-technik - Google Patents

Aufreinigung von fc-tact-fusionsproteinen unter verwendung der ölkörper-technik

Info

Publication number
ATE509107T1
ATE509107T1 AT08708212T AT08708212T ATE509107T1 AT E509107 T1 ATE509107 T1 AT E509107T1 AT 08708212 T AT08708212 T AT 08708212T AT 08708212 T AT08708212 T AT 08708212T AT E509107 T1 ATE509107 T1 AT E509107T1
Authority
AT
Austria
Prior art keywords
purification
fusion proteins
tact
oil body
body technique
Prior art date
Application number
AT08708212T
Other languages
English (en)
Inventor
Henri Kornmann
Gianni Baer
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of ATE509107T1 publication Critical patent/ATE509107T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Sludge (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT08708212T 2007-01-26 2008-01-25 Aufreinigung von fc-tact-fusionsproteinen unter verwendung der ölkörper-technik ATE509107T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88668107P 2007-01-26 2007-01-26
EP07101233 2007-01-26
PCT/EP2008/050886 WO2008090217A1 (en) 2007-01-26 2008-01-25 Purification of fc-tact fusion proteins using the oilbody technology

Publications (1)

Publication Number Publication Date
ATE509107T1 true ATE509107T1 (de) 2011-05-15

Family

ID=38143807

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08708212T ATE509107T1 (de) 2007-01-26 2008-01-25 Aufreinigung von fc-tact-fusionsproteinen unter verwendung der ölkörper-technik

Country Status (9)

Country Link
US (1) US20100063257A1 (de)
EP (1) EP2121931B1 (de)
JP (1) JP2010516744A (de)
AT (1) ATE509107T1 (de)
AU (1) AU2008208837A1 (de)
CA (1) CA2674213A1 (de)
ES (1) ES2366593T3 (de)
IL (1) IL199752A (de)
WO (1) WO2008090217A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI377954B (en) * 2009-11-25 2012-12-01 Univ China Medical Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein
WO2019074983A1 (en) 2017-10-10 2019-04-18 Alpine Immune Sciences, Inc. CTLA-4 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
WO2021226551A1 (en) 2020-05-08 2021-11-11 Alpine Immune Sciences, Inc. April and baff inhibitory immunomodulatory proteins and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1235692A (en) 1991-01-18 1992-08-27 Synergen, Inc. Methods for treating tumor necrosis factor mediated diseases
ES2337091T3 (es) * 1996-11-27 2010-04-20 Genentech, Inc. Purificacion por afinidad de polipeptido en una matriz de proteina.
US5856452A (en) 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
US5969102A (en) 1997-03-03 1999-10-19 St. Jude Children's Research Hospital Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
TR200101998T2 (tr) 1999-01-07 2002-06-21 Zymogenetics, Inc. Çözünür reseptör BR 43x2 ve kullanım metodları
EA010594B1 (ru) * 2001-05-24 2008-10-30 Займодженетикс, Инк. Слитые белки taci-иммуноглобулина
CA2473144C (en) * 2002-02-05 2013-05-28 Genentech, Inc. Protein purification
RU2409591C2 (ru) * 2003-10-27 2011-01-20 Вайет Удаление агрегатов с высокой молекулярной массой путем хроматографии на гидроксиапатитах
JP2010510963A (ja) * 2006-06-14 2010-04-08 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー セラミックヒドロキシアパタイトを使用する抗体の精製方法

Also Published As

Publication number Publication date
EP2121931B1 (de) 2011-05-11
IL199752A (en) 2012-07-31
ES2366593T3 (es) 2011-10-21
IL199752A0 (en) 2010-04-15
WO2008090217A1 (en) 2008-07-31
AU2008208837A1 (en) 2008-07-31
US20100063257A1 (en) 2010-03-11
CA2674213A1 (en) 2008-07-31
JP2010516744A (ja) 2010-05-20
EP2121931A1 (de) 2009-11-25

Similar Documents

Publication Publication Date Title
SG162687A1 (en) Caustic stable chromatography ligands
ATE526017T1 (de) Abscheidung von polyelektrolyten und reinigung von antikörpern
DE602006011482D1 (de) Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen
EA200971142A1 (ru) Система экспрессии гетерологичных и гомологичных целлюлаз
UA110600C2 (uk) Спосіб отримання захищених похідних l-аланіну
DE602008006293D1 (de) System zur Verschleißminderung von Gelenkoberflächenimplantaten
SG10201807877TA (en) Hybrid immunoglobulin containing non-peptidyl linkage
DK1984517T3 (da) Fremgangsmåde til modulering af rekombinante proteiners mannoseindhold
DK2061897T3 (da) Fed-batch-fermenteringsproces med høj celledensitet til fremstilling af rekombinant protein
DE602006006765D1 (de) Verfahren zur Identifizierung von GLP-1-Sekretionsförderern
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
DE602006014126D1 (de) Zusammensetzungen und verfahren zur trennung von fusionsproteinen
ZA200900836B (en) Process for the purification of FC-fusion proteins
MX347257B (es) Solido de gamma-carbolinas fusionadas con heterociclos substituidos.
MX2016000611A (es) Fusocinas que implican citocinas con una afinidad de union al receptor considerablemente menor.
DK2061803T4 (da) Fremgangsmåde til oprensning af fc-holdige proteiner
AR065373A1 (es) Proteinas de fusion de inmunoglobulina y metodos de elaboracion
ATE474917T1 (de) Verfahren zur erhöhung der in-vivo-gewinnung therapeutischer polypeptide
EP2170373A4 (de) Thermostabilisierung von proteinen
ATE484749T1 (de) Von anti-trichinella-antikörpern erkannte polypeptide und ihre verwendung
PL2201120T3 (pl) Systemy białek fuzyjnych GCSF odpowiednie do wysokiej ekspresji peptydów
EP1916302A4 (de) Verfahren zur herstellung von lymphozyten
IN2014DN06660A (de)
DE602007002539D1 (de) Prozesssteuerungssystem zur Erzeugung von Funktionsblöcken
WO2009131698A3 (en) PHOSPHORYLATED RECOMBINANT N-ACETYL-alpha-D- GLUCOSAMINIDASE (NaGlu) AND USES THEREOF

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties